S3F0 fundamentals
SANTHERA PHARMACEUTICALS HOLDING LTD. financial statements, including revenue, expenses, profit, and loss
The total revenue of S3F0 for the last semiannual is 107.05 M EUR, and it's 2554.41% higher compared to the previous semiannual. The net income of H2 23 is 84.06 M EUR.
0.00
Total revenue
Gross profit
Operating income
Pretax income
Net income
Currency: EUR
TTM